Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scanarini

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
European Journal of Endocrinology|February 9, 2007
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imagingR M Testa, N Albiger, G Occhi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Molecular genetic studies of sporadic pituitary tumorsM D Boggild, S Jenkinson, M Pistorello, et al.
Carcinogenesis|July 1, 1995
GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gspC W Perrett, R N Clayton, M Pistorello, et al.
Journal of Molecular Endocrinology|October 12, 2005
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitroM C Zatelli, D Piccin, F Tagliati, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 12, 2010
Volumetric MRI analysis of hippocampal subregions in Cushing's disease: a model for glucocorticoid neural modulationT Toffanin, F Nifosì, H Follador, et al.
Journal of Neuroendocrinology|May 11, 2011
The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cellsG Occhi, M Losa, N Albiger, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
European Journal of Endocrinology|February 9, 2007
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imagingR M Testa, N Albiger, G Occhi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1994
Molecular genetic studies of sporadic pituitary tumorsM D Boggild, S Jenkinson, M Pistorello, et al.
Carcinogenesis|July 1, 1995
GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gspC W Perrett, R N Clayton, M Pistorello, et al.
Journal of Molecular Endocrinology|October 12, 2005
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitroM C Zatelli, D Piccin, F Tagliati, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 12, 2010
Volumetric MRI analysis of hippocampal subregions in Cushing's disease: a model for glucocorticoid neural modulationT Toffanin, F Nifosì, H Follador, et al.
Journal of Neuroendocrinology|May 11, 2011
The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cellsG Occhi, M Losa, N Albiger, et al.
Pageof 7